Combination contraceptives: effects on weight (Q24241209)

3

object named as

David A Grimes

0 references

Kenneth F Schulz

4

object named as

Kenneth F Schulz

0 references

author name string

Maria F Gallo

1

0 references

Frans M Helmerhorst

Cochrane Database of Systematic Reviews

5

0 references

publication date

8 October 2008

0 references

published in

0 references

cites work

A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A study comparing a gestoden triphasic formulation with a fixed combination OC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, on lipid metabolism in an open randomized tri

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Changes in androgens during treatment with four low-dose contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Weight change and adverse event incidence with a low-dose oral contraceptive: two randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle contr

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestre

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A Placebo-Controlled Double-Blind Crossover Investigation of the Side Effects Attributed to Oral Contraceptives*†*Presented at the Twenty-Seventh Annual Meeting of the American Fertility Society, New Orleans, Louisiana, March 25–27, 1971.†This

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A double-blind comparison of the efficacy and acceptability of Femodene and Microgynon-30

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Effect of dienogest-containing oral contraceptives on lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A prospective study of the effects of the progestagen content of oral contraceptives on measures of affect, automatization, and perceptual restructuring ability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A Canadian multicentre prospective study on the effects of an oral contraceptive containing 3 mg drospirenone and 30 microg ethinyl oestradiol on somatic and psychological symptoms related to water retention and on body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Effects of two different oral contraceptives on total body water: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Extended regimens of the contraceptive vaginal ring: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 microg on premenstrual symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

An open-label randomized comparative study of oral contraceptives between medications containing 3 mg drospirenone/30 microg ethinylestradiol and 150 microg levonogestrel/30 microg ethinylestradiol in Thai women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 microg ethinylestradio1/75 microg gestodene (Meliane) and 30 microg ethinylestradio1/75 microg gestodene (Gyner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

A comparison between the vaginal ring and oral contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Initiation of Oral Contraceptives Using a Quick Start Compared With a Conventional Start

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Oral contraceptive discontinuation: do side effects matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Direction and impact of language bias in meta-analyses of controlled trials: empirical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

What contributions do languages other than English make on the results of meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Women's satisfaction with birth control: a population survey of physical and psychological effects of oral contraceptives, intrauterine devices, condoms, natural family planning, and sterilization among 1466 women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Weight change with oral contraceptive use and during the menstrual cycle. Results of daily measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Allocation concealment in randomised trials: defending against deciphering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Blinding in randomised trials: hiding who got what.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

Long-interval treatment regimen with a desogestrel-containing oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle co

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Ovarian activity suppression by two different low-dose triphasic oral contraceptives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Shorter pill-free interval in combined oral contraceptives decreases follicular development

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

What women believe about oral contraceptives and the effect of counseling

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Oral contraceptives: side effects and depression in adolescent girls

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

The development of elevated blood pressure while using oral contraceptives: a preliminary report of a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

[Factors associated with weight gain in women using oral contraceptives: results of a French 2001 opinion poll survey conducted on 1665 women]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

A comparison of the cycle control, safety, and efficacy profile of a 21-day regimen of ethinylestradiol 20mug and drospirenone 3mg with a 21-day regimen of ethinylestradiol 20mug and desogestrel 150mug

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Effect of norethisterone and levonorgestrel in low-dose multiphasic oral contraceptives on serum lipids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021

A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003987.PUB3

7 January 2021